alexa Sangita Biswas | OMICS International | University of Ca
ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Sangita Biswas
Sangita Biswas Sangita Biswas
Senior scientist
Department of Biochemistry and Molecular Medicine
University of California

Dr Sangita Biswas received her PhD in neuroscience in 1993 from the Institute of Medical Sciences, Varanasi, India. She then underwent postdoctoral work as a Visiting Fellow in Neuroscience department at the University of New South Wales, Australia. Subsequently, she relocated to the United States as a Postdoctoratal Fellow in the Department of Molecular and Integrative Physiology at the University of Kansas Medical Center, Kansas. In 2002, she became a Research Assistant Professor at the University of Kansas Medical Center. During this time she published several important studies on the treatment for Globoid Cell Leukodystrophy and the EAE model of Multiple Sclerosis. In 2004, she joined MidAmerica Neuroscience Institute, Kansas City, as the Director of their Multiple Sclerosis research team. Here she was involved in several early drug development programs for the treatment of multiple sclerosis and other related autoimmune demyelinating diseases. In 2011, she joined as a Senior Scientist at the University of California, Davis. Currently, she is also an investigator at the Shriners Hospital for Children, Sacramento. Her scientific interests are therapeutic interventions for remyelination in demyelinating diseases. Her current projects are centered on direct in vivo and in vitro reprogramming of somatic cells into oligodendrocyte precursor cells. She is also interested in developing human stem cell based therapies in demyelinating diseases such as Multiple Sclerosis. She also makes every effort toward translating fundamental insights into discovery of new therapeutic strategies for human disorders.

Research Interest

Molecular Mechanisms of Neurological Disorders, new therapeutic strategies for human disorders, treatment of multiple sclerosis


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version